Research Article
Reporting Quality of Randomized Controlled Trials for the Treatment of Eczema with Chinese Patent Medicine Based on the CONSORT-CHM Formulas 2017
Table 4
The reporting number and percentage for each item of the CONSORT-CHM formulas 2017.
| Section | Topic | Item number | n/N | % |
| Title, abstract, and keywords | Title | 1a | 4/144 | 2.78 | Abstract | 1b | 100/144 | 69.44 | Keywords | 1c | 5/144 | 3.47 | Introduction | Background | 2a | 99/144 | 68.75 | Objectives | 2b | 35/144 | 24.31 | Methods | Trial design | 3a | 142/144 | 98.61 | 3b | 0/0 | 0 | Participants | 4a | 82/144 | 56.94 | 4b | 123/144 | 85.42 | Interventions | 5 | 114/144 | 79.17 | Outcomes | 6a | 106/144 | 73.61 | 6b | 0/0 | 0 | Sample size | 7a | 1/144 | 0.69 | 7b | 0/0 | 0 | Sequence generation | 8a | 34/144 | 23.61 | 8b | 4/144 | 2.78 | Allocation concealment mechanism | 9 | 1/144 | 0.69 | Implementation | 10 | 1/144 | 0.69 | Blinding | 11a | 5/144 | 3.47 | 11b | 3/6 | 50 | Statistical methods | 12a | 115/144 | 79.86 | 12b | 4/6 | 66.67 | Results | Participant flow | 13a | 144/144 | 100 | 13b | 137/144 | 95.14 | Recruitment | 14a | 119/144 | 82.64 | 14b | 0/0 | 0 | Baseline data | 15 | 8/144 | 5.56 | Numbers analyzed | 16 | 144/144 | 100 | Outcomes and estimation | 17a | 0/144 | 0 | 17b | 0/143 | 0 | Ancillary analyses | 18 | 6/6 | 100 | Harms | 19 | 120/144 | 83.33 | Discussion | Limitations | 20 | 8/144 | 5.56 | Generalizability | 21 | 74/144 | 51.39 | Interpretation | 22 | 118/144 | 81.94 | Other information | Registration | 23 | 1/144 | 0.69 | Protocol | 24 | 2/144 | 1.39 | Funding | 25 | 9/144 | 6.25 |
|
|
CONSORT-CHM formulas, Consolidated Standards of Reporting Trials for Chinese herbal medicine formulas.
|